Skip to content
  • Saturday, 15 August 2026
  • 12:24 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • ADA Conference Marked by Landmark GLP-1 Trial Results Amidst Unprecedented Scientific Dissent and Police Intervention
Laboratory Automation & Robotics

ADA Conference Marked by Landmark GLP-1 Trial Results Amidst Unprecedented Scientific Dissent and Police Intervention

Lana Keisha Jul 20, 2026 0

The annual national conference of the American Diabetes Association (ADA) this week served as a dual stage: a vibrant forum…

Read More
Laboratory Automation & Robotics

ADA Conference Unveils Groundbreaking GLP-1 Advances Amidst Controversy Over Scientific Dissent

Lana Keisha Jun 21, 2026 0

The annual scientific sessions of the American Diabetes Association (ADA) this week served as a pivotal platform for significant announcements…

Read More
Unraveling the Malaria Parasite’s Molecular Choreography: A Specialized Protein Emerges as a Potent Drug TargetNew Research Deciphers the Efficiency Paradox of Lead-Halide Perovskites in Next-Generation Solar CellsAmerican Diabetes Association Conference Sees Landmark GLP-1 Trial Results Amidst Unprecedented Controversy Over Researcher RemovalFreediving’s Extreme Physiology Offers Vital Clues to Lung and Heart Function, Potentially Enhancing Treatments for Common Conditions
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ